Willow Biosciences Inc. (CANSF)
USD 0.04
(-4.55%)
USD 0.04
(-4.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.92 Million | -13.86 Million | -18.22 Million | -12.78 Million | -9.16 Million | -1.33 Million |
| Net Income | -13.02 Million | -14.81 Million | -6.14 Million | -33.94 Million | -44.56 Million | -1.64 Million |
| Depreciation & Amortization | 1.83 Million | 2.64 Million | 3.19 Million | 3.18 Million | 2.16 Million | 46.39 Thousand |
| Deferred income taxes | -15 Thousand | -3.75 Million | -16.69 Million | 17.2 Million | -1.58 Million | - |
| Stock-based compensation | 420 Thousand | 1.46 Million | 1.7 Million | 951 Thousand | 2.58 Million | 588.3 Thousand |
| Change in working capital | -207 Thousand | 129 Thousand | -316 Thousand | -211 Thousand | -351.04 Thousand | -367.03 Thousand |
| Other non-cash items | 80 Thousand | 473 Thousand | 27 Thousand | 40 Thousand | 32.57 Million | 43.81 Thousand |
| Investing Cash Flow | 3.46 Million | -4.55 Million | -1.67 Million | -837 Thousand | -6.83 Million | -202.84 Thousand |
| Investments in PPE | -619 Thousand | -682 Thousand | -1.76 Million | -997 Thousand | -6.71 Million | -202.84 Thousand |
| Acquisitions | 7000.00 | 123 Thousand | 119 Thousand | 54 Thousand | 57.85 Thousand | - |
| Investment purchases | - | -4.02 Million | - | - | - | - |
| Sales/Maturities of investments | 4 Million | -123 Thousand | - | - | - | - |
| Other Investing Activities | 77 Thousand | 149 Thousand | -27 Thousand | 106 Thousand | -176.42 Thousand | - |
| Financing Cash Flow | -318 Thousand | -723 Thousand | 34.12 Million | 9.89 Million | 35.26 Million | 1.31 Million |
| Debt repayment | -758 Thousand | -723 Thousand | -637 Thousand | -651 Thousand | -493.05 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 26.73 Million | 10.51 Million | 27.37 Million | - |
| Other Financing Activities | -64 Thousand | - | 8.03 Million | 25 Thousand | 8.38 Million | 1.31 Million |
| Accounts receivables | - | - | - | - | - | -326.61 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -207 Thousand | 129 Thousand | -316 Thousand | -211 Thousand | -351.04 Thousand | -40.41 Thousand |
| Cash at beginning of period | 11 Million | 30.11 Million | 15.89 Million | 19.64 Million | 372.34 Thousand | 588.51 Thousand |
| Cash at end of period | 3.14 Million | 11 Million | 30.11 Million | 15.89 Million | 19.64 Million | 372.34 Thousand |
| Capital Expenditure | -619 Thousand | -682 Thousand | -1.76 Million | -997 Thousand | -6.71 Million | -202.84 Thousand |
| Effect of forex changes on cash | -89 Thousand | 26 Thousand | -1000.00 | -22 Thousand | - | - |
| Net cash flow / Change in cash | -7.86 Million | -19.11 Million | 14.22 Million | -3.74 Million | 19.27 Million | -216.17 Thousand |
| Free Cash Flow | -11.53 Million | -14.54 Million | -19.99 Million | -13.77 Million | -15.87 Million | -1.53 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.68 Million | -2.35 Million | -13.02 Million | -2.42 Million | -2.23 Million | -3.6 Million |
| Depreciation & Amortization | 353 Thousand | 352 Thousand | 1.83 Million | 377 Thousand | 558 Thousand | 444 Thousand |
| Deferred income taxes | - | - | -15 Thousand | -15 Thousand | -5000.00 | 2000.00 |
| Stock-based compensation | 106 Thousand | 158 Thousand | 420 Thousand | 82 Thousand | -346 Thousand | 156 Thousand |
| Change in working capital | 456 Thousand | 192 Thousand | -207 Thousand | 849 Thousand | -314 Thousand | -701 Thousand |
| Other non-cash items | 454 Thousand | 910 Thousand | 80 Thousand | 65 Thousand | -13 Thousand | 20 Thousand |
| Investing Cash Flow | -1000.00 | 135 Thousand | 3.46 Million | 6000.00 | -14 Thousand | -1000.00 |
| Investments in PPE | - | - | -619 Thousand | -58 Thousand | -30 Thousand | -7000.00 |
| Acquisitions | - | 135 Thousand | 7000.00 | 7000.00 | - | - |
| Investment purchases | -1000.00 | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 4 Million | -20 Thousand | 21 Thousand | 1000.00 |
| Other Investing Activities | -1000.00 | 135 Thousand | 77 Thousand | 77 Thousand | -5000.00 | 5000.00 |
| Financing Cash Flow | 346 Thousand | 71 Thousand | -318 Thousand | 267 Thousand | -115 Thousand | -296 Thousand |
| Debt repayment | -200 Thousand | -198 Thousand | -758 Thousand | -758 Thousand | -415 Thousand | -232 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 270 Thousand | - | - | - | - |
| Other Financing Activities | 546 Thousand | -1000.00 | -64 Thousand | -300 Thousand | 300 Thousand | -64 Thousand |
| Accounts receivables | 135 Thousand | 18 Thousand | - | - | - | - |
| Accounts payables | 170 Thousand | -160 Thousand | - | - | - | - |
| Inventory | 92 Thousand | 1000.00 | - | - | - | - |
| Other working capital | 59 Thousand | 333 Thousand | -207 Thousand | 849 Thousand | -314 Thousand | -701 Thousand |
| Cash at beginning of period | 1.62 Million | 3.14 Million | 11 Million | 3.98 Million | 6.46 Million | 10.46 Million |
| Cash at end of period | 1.23 Million | 1.62 Million | 3.14 Million | 3.14 Million | 3.67 Million | 6.46 Million |
| Capital Expenditure | - | - | -619 Thousand | -58 Thousand | -30 Thousand | -7000.00 |
| Effect of forex changes on cash | 4000.00 | 18 Thousand | -89 Thousand | -42 Thousand | -7000.00 | -21 Thousand |
| Net cash flow / Change in cash | -383 Thousand | -1.52 Million | -7.86 Million | -835 Thousand | -2.78 Million | -4 Million |
| Free Cash Flow | -733 Thousand | -1.74 Million | -11.53 Million | -1.12 Million | -2.38 Million | -3.69 Million |
293780
950160
129260
1313
CPA
RSE